Evidence map›Paper›PMID 32217350›Full record

ArticleThe Journal of surgical research2020

Humanized Anti-Tumor-Associated Glycoprotein-72 for Submillimeter Near-Infrared Detection of Colon Cancer in Metastatic Mouse Models.

Hannah M Hollandsworth, Siamak Amirfakhri, Filemoni Filemoni, Robert M Hoffman, Justin Molnar, Paul J Yazaki, Michael Bouvet

Open access · greenAbstract read
In one paragraph

Article in The Journal of surgical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Minimally invasive surgeryWorld journal of clinical cases · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Hannah M HollandsworthDepartment of Surgery, University of California San Diego, San Diego, California; Moores Cancer Center, University of California San Diego, San Diego, California; Department of Surgery, VA San Diego Healthcare System, San Diego, California.
Siamak AmirfakhriDepartment of Surgery, University of California San Diego, San Diego, California; Moores Cancer Center, University of California San Diego, San Diego, California; Department of Surgery, VA San Diego Healthcare System, San Diego, California.
Filemoni FilemoniDepartment of Surgery, University of California San Diego, San Diego, California; Moores Cancer Center, University of California San Diego, San Diego, California; Department of Surgery, VA San Diego Healthcare System, San Diego, California.
Robert M HoffmanDepartment of Surgery, University of California San Diego, San Diego, California; Moores Cancer Center, University of California San Diego, San Diego, California; Department of Surgery, VA San Diego Healthcare System, San Diego, California; AntiCancer, Inc., San Diego, California.
Justin MolnarBeckman Research Institute of the City of Hope, Department of Molecular Imaging and Therapy, Duarte, California.
Paul J YazakiBeckman Research Institute of the City of Hope, Department of Molecular Imaging and Therapy, Duarte, California.
Michael BouvetDepartment of Surgery, University of California San Diego, San Diego, California; Moores Cancer Center, University of California San Diego, San Diego, California; Department of Surgery, VA San Diego Healthcare System, San Diego, California. Electronic address: mbouvet@ucsd.edu.
University of California San Diego · USCity Of Hope National Medical Center · USUC San Diego Health System · US

Funding

UCSD Cancer Center Training Program in Drug DevelopmentT32CA121938 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Michael Bouvet, Dwayne G. Stupack · 2006 to 2026
$10.3M
Development of Near Infrared Fluorescence-Guided Surgical Navigation and Tumor Specific Photoimmunotherapy for Improved Outcomes for GI CancersI01BX003856 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI BOUVET, MICHAEL · 2018 to 2022
–
CMA- Marker-assisted prevention and risk stratification (MAPRS): Mucin signatures and molecular imaging for the early detection of colorectal cancer.I01BX004494 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI BOUVET, MICHAEL · 2020 to 2023
–
BLRD VA I01 BX003856BLRD VA I01 BX004494NCI NIH HHS T32 CA121938
6 · The paper itself

Abstract

backgroundTumor-associated glycoprotein (TAG)-72 is a pancarcinoma antigen that is overexpressed in greater than 80% of colorectal adenocarcinomas. CC49 is a TAG-72-specific antibody. The aim of the present study was to demonstrate selective imaging of colon tumors and metastases with the humanized TAG-72 antibody (anti-huCC49) conjugated to a near-infrared fluorophore in orthotopic mouse models.

methodsAnti-huCC49 was conjugated to near-infrared dye IR800CW. Mouse imaging was performed with the Pearl Trilogy Small Animal and FLARE Imaging Systems. Subcutaneous mouse models of colon cancer cell line LS174T were used to determine the optimal dose of administration and timing of imaging. Orthotopic mouse models of LS174T were established by surgical orthotopic implantation of LS174T tumors onto the serosa of the cecum. Peritoneal carcinomatosis models were established by injection of LS174T cells into the peritoneum of nude mice. Mice were administered anti-huCC49-IR800 via tail vein injection. Mice were euthanized 72 h later and imaged after laparotomy.

resultsSubcutaneous LS174T xenografts demonstrated optimal tumor detection 72 h after administration with 50 μg anti-huCC49-IR800CW. Tumors were visualized with fluorescence imaging with a mean tumor-to-liver ratio of 7.39 (standard deviation: 2.76). In the orthotopic model, metastases smaller than 1 mm were fluorescently visualized that were invisible with bright light.

conclusionsAnti-huCC49-IR800CW provides sensitive and specific imaging of colon cancer and metastases at a submillimeter resolution in metastatic nude mice models. This provides a promising near-infrared probe for the imaging of colon cancer and metastases for preoperative diagnosis and fluorescence-guided surgery.

Indexed as

Alkanesulfonic AcidsAnimalsAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAntigens, NeoplasmCell Line, TumorColonic NeoplasmsFluorescent DyesHumansImmunoconjugatesIndolesMicePeritoneal NeoplasmsPreoperative CareSpectroscopy, Near-InfraredSurgery, Computer-AssistedAlkanesulfonic AcidsAntibodies, Monoclonal, HumanizedAntibodies, NeoplasmAntigens, NeoplasmB72.3 antibodyFluorescent DyesImmunoconjugatesIndolesIRDye 800CW NHS estertumor-associated antigen 72Colon cancerFluorescence imagingHumanized anti-TAG-72MetastasesNear-infrared imagingOrthotopic nude mice

Identifiers

PMID32217350
PMCPMC7295682
OpenAlexW3013972926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.